R. Schreiber, L. Old, and M. Smyth, Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion, Science, vol.331, issue.6024, pp.1565-70, 2011.
DOI : 10.1126/science.1203486

R. Kennedy and E. Celis, T cells in anti-tumor immune responses, Immunological Reviews, vol.161, issue.1, pp.129-173, 2008.
DOI : 10.1038/nbt1215

W. Fridman, F. Pagès, C. Sautès-fridman, and J. Galon, The immune contexture in human tumours: impact on clinical outcome, Nature Reviews Cancer, vol.29, issue.4, pp.298-306, 2012.
DOI : 10.1038/nrc3245

L. Zitvogel, O. Kepp, and G. Kroemer, Immune parameters affecting the efficacy of chemotherapeutic regimens, Nature Reviews Clinical Oncology, vol.23, issue.3, pp.151-60, 2011.
DOI : 10.1038/nrclinonc.2010.223

Y. Godet, E. Fabre, M. Dosset, M. Lamuraglia, E. Levionnois et al., Analysis of Spontaneous Tumor-Specific CD4 T-cell Immunity in Lung Cancer Using Promiscuous HLA-DR Telomerase-Derived Epitopes: Potential Synergistic Effect with Chemotherapy Response, Clinical Cancer Research, vol.18, issue.10, pp.2943-53, 2012.
DOI : 10.1158/1078-0432.CCR-11-3185
URL : https://hal.archives-ouvertes.fr/inserm-00723050

S. Topalian, F. Hodi, J. Brahmer, S. Gettinger, D. Smith et al., Safety, Activity, and Immune Correlates of Anti???PD-1 Antibody in Cancer, New England Journal of Medicine, vol.366, issue.26, pp.2443-54, 2012.
DOI : 10.1056/NEJMoa1200690

D. Hong, L. Vence, G. Falchook, L. Radvanyi, C. Liu et al., BRAF(V600) Inhibitor GSK2118436 Targeted Inhibition of Mutant BRAF in Cancer Patients Does Not Impair Overall Immune Competency, Clinical Cancer Research, vol.18, issue.8, pp.2326-2361, 2012.
DOI : 10.1158/1078-0432.CCR-11-2515

L. Zitvogel, L. Apetoh, F. Ghiringhelli, and G. Kroemer, Immunological aspects of cancer chemotherapy, Nature Reviews Immunology, vol.313, issue.1, pp.59-73, 2008.
DOI : 10.1038/nri2216

B. Weide, H. Zelba, E. Derhovanessian, A. Pflugfelder, T. Eigentler et al., Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis, Journal of Clinical Oncology, vol.30, issue.15, pp.1835-1876, 2012.
DOI : 10.1200/JCO.2011.40.2271

C. Chen, H. Maecker, and P. Lee, Development and dynamics of robust T-cell responses to CML under imatinib treatment, Blood, vol.111, issue.11, pp.5342-5351, 2008.
DOI : 10.1182/blood-2007-12-128397